Fabric Genomics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Fabric Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10279
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fabric Genomics Inc (Fabric), formerly Omicia Inc, is a healthcare solutions provider that offers genome interpretation solutions. The company offers Opal, a cloud-based informatics platform that helps to analyze and interpret genomes by prioritizing disease-causing variants and genes. Fabric utilizes a probabilistic search tool VAAST, a disease gene finder and variant scoring algorithm to identify the genetic basis of various conditions, including childhood diseases, cancer, and cardiovascular diseases. The company caters to commercial clinical laboratories, country sequencing programs, hospital core labs, and research institutions. Fabric is headquartered in Oakland, California, the US.

Fabric Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fabric Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fabric Genomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fabric Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fabric Genomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Fabric Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fabric Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Omicia Raises USD23 Million in Series B Financing Round 10
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 11
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 12
Spiral Genetics Raises USD0.2 Million in Venture Financing 13
Omicia Raises US$7 Million In Series A Financing Round 14
Spiral Genetics Raises US$3 Million In Series A Financing 16
Spiral Genetics Raises USD0.1 Million in Venture Financing 17
Partnerships 18
Edico Genome Enters Into Partnership With Fabric Genomics 18
Fabric Genomics and TOMA Biosciences Enter into Partnership 19
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 20
Acquisition 21
Omicia Acquires Spiral Genetics 21
Fabric Genomics Inc – Key Competitors 22
Fabric Genomics Inc – Key Employees 23
Fabric Genomics Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Mar 21, 2017: Fabric Genomics and Sentieon Sign Strategic Partnership to Bring Advanced Genomic Analysis Capabilities to the Clinical Market 25
Product News 26
Jun 16, 2018: UK Pediatric Hospital’s Use of Fabric Genomics Platform to Achieve Faster and More Accurate Genome Interpretation to Be Discussed at Symposium 26
Jan 10, 2017: Omicia Joins Cancer Moonshot’s Blood Profiling Atlas to Advance Circulating Tumor DNA Research 27
Other Significant Developments 28
Jun 15, 2018: Fabric Genomics Expands Commercial Leadership With New Clinical Customers Across the Globe 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Fabric Genomics Inc, Medical Equipment, Key Facts 2
Fabric Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Fabric Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fabric Genomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fabric Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fabric Genomics Inc, Deals By Market, 2012 to YTD 2018 8
Fabric Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Omicia Raises USD23 Million in Series B Financing Round 10
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 11
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 12
Spiral Genetics Raises USD0.2 Million in Venture Financing 13
Omicia Raises US$7 Million In Series A Financing Round 14
Spiral Genetics Raises US$3 Million In Series A Financing 16
Spiral Genetics Raises USD0.1 Million in Venture Financing 17
Edico Genome Enters Into Partnership With Fabric Genomics 18
Fabric Genomics and TOMA Biosciences Enter into Partnership 19
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 20
Omicia Acquires Spiral Genetics 21
Fabric Genomics Inc, Key Competitors 22
Fabric Genomics Inc, Key Employees 23
Fabric Genomics Inc, Subsidiaries 24

List of Figures
Fabric Genomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Fabric Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Fabric Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Fabric Genomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Fabric Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fabric Genomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Fabric Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fabric Genomics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Fabric Genomics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Midea Group Co Ltd:企業の戦略・SWOT・財務情報
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Gland Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • Rexel S.A.:企業の戦略・SWOT・財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lenovo Group Limited:企業の戦略・SWOT・財務情報
    Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report Summary Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Its I'm InTouch provides a secure and easy to use PC remote access softw …
  • Expanesthetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Expanesthetics Inc (Expanesthetics) is a developer of anesthetic and analgesic agents. The company develops inhalation anesthetic agents used in surgical procedures. It offers CNS drug development programs for various types of pains and indications such as post-operative pain, traumatic inju …
  • Metsa Group:企業の戦略・SWOT・財務情報
    Metsa Group - Strategy, SWOT and Corporate Finance Report Summary Metsa Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Intersurgical Ltd.:企業の戦略的SWOT分析
    Intersurgical Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Impax Laboratories Inc (IPXL)-製薬・医療分野:企業M&A・提携分析
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …
  • Nordic Bioscience AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Nordic Bioscience AS (Nordic Bioscience), formerly Danish Biotech Co is a preclinical and clinical drug development company that offers serological biochemical solutions. The company offers diagnostic products, laboratory kits and biochemical assays. It provides degradation biomarkers, forma …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Accenture Plc (ACN):企業の財務・戦略的SWOT分析
    Accenture Plc (ACN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • HealthTronics Inc:医療機器:M&Aディール及び事業提携情報
    Summary HealthTronics Inc (HealthTronics), a subsidiary of Altaris Capital Partners, LLC, carries out manufacturing, marketing and distribution of lithotripters, cryoblation devices and nerve monitoring equipment. The various products and services offered by the company include lithotripsy services, …
  • GlobalSCAPE Inc (GSB):企業の財務・戦略的SWOT分析
    Summary GlobalSCAPE Inc (GlobalSCAPE) is a technology company that offers secure information exchange solutions. The company offers EFT platform products such as EFT enterprise, EFT express, public and private cloud, collaboration, automation and efficiency, protocols, security, compliance and analy …
  • Inivata Ltd:企業の製品パイプライン分析
    Summary Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotid …
  • Nabors Industries Ltd (NBR):石油・ガス:M&Aディール及び事業提携情報
    Summary Nabors Industries Ltd (Nabors) is an oil and gas contract services provider that offers offshore platform work over and drilling rigs. It also provides directional drilling services, performance tools and innovative drilling technologies and drilling instrumentation and software to the world …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務情報
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆